1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. APTOSE BIOSCIENCES INC
Aptose Biosciences Inc XNAS: APTOF

Watchlist

Portfolio

Share


Insider Trading disclosures for Aptose Biosciences Inc

The latest disclosure was made by William G. Rice in Aptose Biosciences Inc where a trade of 100,000 Common Shares done at an average price of $0.2 was reported to US exchanges on Nov. 25, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
William G. Rice Director, Chair, President & CEO Purchase of securities on an exchange or from another person at price $ 0.20 per share. 25 Nov 2024 100,000 613,252 (0%) 0% 0.2 20,000 Common Shares
William G. Rice Director, Chair, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 Nov 2024 50,000 50,000 - - Warrants
Vincent Mark D. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2024 3,333 3,333 - - Director Stock Option (Right to Buy)
Rice G. William Director, Chair, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2024 70,000 70,000 - - Employee Stock Option (Right to Buy)
Erich M. Platzer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2024 3,333 3,333 - - Director Stock Option (Right to Buy)
Bernd Seizinger R. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2024 3,333 3,333 - - Director Stock Option (Right to Buy)
Warren Whitehead Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2024 3,333 3,333 - - Director Stock Options (Right to Buy)
Philippe Ledru Sr VP & Ch Commerical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2024 11,000 11,000 - - Employee Stock Option (Right to Buy)
Denis R. Burger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2024 3,333 3,333 - - Director Stock Option (Right to Buy)
Carol Gail Ashe Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2024 3,333 3,333 - - Director Stock Option (Right to Buy)
Rafael Bejar Sr VP & Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2024 35,000 35,000 - - Employee Stock Option (Right to Buy)
Fletcher Payne Sr VP and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2024 55,000 55,000 - - Employee Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters